Correlation Between PureTech Health and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both PureTech Health and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PureTech Health and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PureTech Health PLC and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on PureTech Health and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PureTech Health with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of PureTech Health and Mineralys Therapeutics,.
Diversification Opportunities for PureTech Health and Mineralys Therapeutics,
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between PureTech and Mineralys is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding PureTech Health PLC and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and PureTech Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PureTech Health PLC are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of PureTech Health i.e., PureTech Health and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between PureTech Health and Mineralys Therapeutics,
Given the investment horizon of 90 days PureTech Health PLC is expected to under-perform the Mineralys Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, PureTech Health PLC is 1.07 times less risky than Mineralys Therapeutics,. The stock trades about -0.01 of its potential returns per unit of risk. The Mineralys Therapeutics, Common is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 1,600 in Mineralys Therapeutics, Common on October 24, 2024 and sell it today you would lose (581.00) from holding Mineralys Therapeutics, Common or give up 36.31% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 98.99% |
Values | Daily Returns |
PureTech Health PLC vs. Mineralys Therapeutics, Common
Performance |
Timeline |
PureTech Health PLC |
Mineralys Therapeutics, |
PureTech Health and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with PureTech Health and Mineralys Therapeutics,
The main advantage of trading using opposite PureTech Health and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PureTech Health position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.PureTech Health vs. Molecular Partners AG | PureTech Health vs. MediciNova | PureTech Health vs. Anebulo Pharmaceuticals | PureTech Health vs. Champions Oncology |
Mineralys Therapeutics, vs. Chemours Co | Mineralys Therapeutics, vs. The Mosaic | Mineralys Therapeutics, vs. Strategic Education | Mineralys Therapeutics, vs. NL Industries |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |